1. Williams T, Mortada R, Porter S. Diagnosis and treatment of polycystic ovary syndrome. Am Fam Physician 2016;94:106-113.PMID:
27419327.
2. Tokmak A, Kokanali D, Timur H, Kuntay Kokanali M, Yilmaz N. Association between anti-Mullerian hormone and insulin resistance in non-obese adolescent females with polycystic ovary syndrome. Gynecol Endocrinol 2016;32:926-930.PMID:
27275748.
3. Graff SK, Mario FM, Ziegelmann P, Spritzer PM. Effects of orlistat vs. metformin on weight loss-related clinical variables in women with PCOS: systematic review and meta-analysis. Int J Clin Pract 2016;70:450-461.PMID:
27228266.
5. Nasrat H, Patra SK, Goswami B, Jain A, Raghunandan C. Study of association of leptin and insulin resistance markers in patients of PCOS. Indian J Clin Biochem 2016;31:104-107.PMID:
26855496.
6. Papalou O, Victor VM, Diamanti-Kandarakis E. Oxidative stress in polycystic ovary syndrome. Curr Pharm Des 2016;22:2709-2722.PMID:
26881435.
7. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.
8. Barber TM, Dimitriadis GK, Andreou A, Franks S. Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance. Clin Med (Lond) 2016;16:262-266.PMID:
27251917.
9. Voelkl J, Pakladok T, Lin Y, Viereck R, Lebedeva A, Kukuk D, et al. Up-regulation of hepatic alpha-2-HS-glycoprotein transcription by testosterone via androgen receptor activation. Cell Physiol Biochem 2014;33:1911-1920.PMID:
25011927.
10. Robinson KN, Teran-Garcia M. From infancy to aging: biological and behavioral modifiers of fetuin-A. Biochimie 2016;124:141-149.PMID:
26740309.
11. Abali R, Celik C, Tasdemir N, Guzel S, Alpsoy S, Yuksel A, et al. The serum protein α2-Heremans-Schmid glycoprotein/fetuin-A concentration and carotid intima-media thickness in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2013;169:45-49.PMID:
23433744.
12. Kucukaydın Z, Duran C, Basaran M, Camlica F, Erdem SS, Basaran A, et al. Plasma total oxidant and antioxidant status after oral glucose tolerance and mixed meal tests in patients with polycystic ovary syndrome. J Endocrinol Invest 2016;39:1139-1148.PMID:
27300033.
13. Demir B, Cengiz H, Ungan I, Gedikbasi A, Karakoc G, Demir E, et al. The relationship between epicardial adipose tissue thickness and oxidative stress parameters in patients with isolated polycystic ovary syndrome. Gynecol Endocrinol 2015;31:531-535.PMID:
26340353.
14. Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007;39:175-191.PMID:
17695343.
15. Incebiyik A, Camuzcuoglu H, Vural M, Hilali NG, Camuzcuoglu A, Seker A, et al. Assessment of apoptotic activity dysregulation and oxidative stress in the development of epithelial ovarian cancer: a case-controlled descriptive analysis. Gynecol Obstet Invest 2016;81:71-77.PMID:
26045161.
17. Hizli S, Abaci A, Ozdemir O, Akelma Z, Akin O. Relation of fetuin A levels with cardiac, subcutaneous lipid accumulation and insulin resistance parameters in Turkish obese children. J Pediatr Endocrinol Metab 2016;29:669-673.PMID:
27049616.
18. Kozakowski J, Jeske W, Zgliczynski W. Fetuin-A levels in lean and obese women with polycystic ovary syndrome. Endokrynol Pol 2014;65:371-376.PMID:
25301487.
19. Enli Y, Fenkci SM, Fenkci V, Oztekin O. Serum fetuin-A levels, insulin resistance and oxidative stress in women with polycystic ovary syndrome. Gynecol Endocrinol 2013;29:1036-1039.PMID:
23961784.
20. Gulhan I, Bozkaya G, Oztekin D, Uyar I, Kebapcilar AG, Pamuk B. Serum fetuin-A levels in women with polycystic ovary syndrome. Arch Gynecol Obstet 2012;286:1473-1476.PMID:
22865037.
21. Ou HY, Yang YC, Wu HT, Wu JS, Lu FH, Chang CJ. Serum fetuin-A concentrations are elevated in subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes. Clin Endocrinol (Oxf) 2011;75:450-455.PMID:
21521338.
22. Yin L, Cai WJ, Chang XY, Li J, Su XH, Zhu LY, et al. Association between fetuin-A levels with insulin resistance and carotid intimamedia thickness in patients with new-onset type 2 diabetes mellitus. Biomed Rep 2014;2:839-842.PMID:
25279156.
23. Lim SS, Norman RJ, Davies MJ, Moran LJ. The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis. Obes Rev 2013;14:95-109.PMID:
23114091.
24. Uyanikoglu H, Sabuncu T, Dursun H, Sezen H, Aksoy N. Circulating levels of apoptotic markers and oxidative stress parameters in women with polycystic ovary syndrome: a case-controlled descriptive study. Biomarkers 2017;22:643-647.PMID:
27899026.
25. Isik H, Aynioglu O, Timur H, Sahbaz A, Harma M, Can M, et al. Is xanthine oxidase activity in polycystic ovary syndrome associated with inflammatory and cardiovascular risk factors? J Reprod Immunol 2016;116:98-103.PMID:
27295433.
26. Zuo T, Zhu M, Xu W. Roles of oxidative stress in polycystic ovary syndrome and cancers. Oxid Med Cell Longev 2016;2016:8589318. PMID:
26770659.